Hair Relaxer Litigation Update: MDL No. 3060 Timeline, Settlements, and Bellwether Outlook

Subject Matter Expert –
Woman With Long Hair

The chemical hair relaxer litigation continues to advance across federal and state courts as one of the largest active product liability dockets in the United States. Centralized in the U.S. District Court for the Northern District of Illinois as In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL No. 3060) before U.S. District Judge Mary M. Rowland, the federal litigation has grown to 12,743 pending actions (with more than 17,018 total actions filed) according to the U.S. Judicial Panel on Multidistrict Litigation (JPML) November 2, 2026 report.

Lawsuits allege that long-term use of chemical hair relaxers and straighteners exposed consumers—predominantly Black and Brown women—to formaldehyde, phthalates, and other endocrine-disrupting chemicals, increasing the risk of uterine cancer, ovarian cancer, endometrial cancer, and related reproductive injuries. For law firms managing large claimant inventories, staying current on discovery rulings, expert admissibility orders, and state-court resolutions is essential to preparing dockets for bellwether review and eventual settlement evaluation.

Latest Developments in the Hair Relaxer Litigation (November 2026)

First Hair Relaxer Trial Ends in Confidential Settlements in Cook County

On November 16, 2026, L’Oréal USA and several co-defendant manufacturers reached confidential settlements with four plaintiffs in Cook County Circuit Court in Illinois, resolving the first hair relaxer cancer claims to reach trial just one week after jury selection began. As reported by Reuters Legal, the settlement terms were not disclosed, no jury verdict was reached on causation, and defendants continue to deny liability.

Federal MDL No. 3060 Moves Toward September 2027 Bellwether Trial

The Cook County settlements resolve only those four individual state-court actions and do not establish a global settlement or payout framework for the federal multidistrict litigation. Within MDL No. 3060:

  • First Federal Bellwether Trial Date: Judge Rowland scheduled the first federal bellwether trial to begin on September 7, 2027 (MDL No. 3060 Docket Entry 2041). The parties agreed on a final pool of five bellwether trial cases on October 22, 2026.

  • General Causation Expert Rulings: Following Rule 702 (Daubert) challenges, Judge Rowland issued two major admissibility orders allowing five of plaintiffs’ general causation experts to testify regarding uterine and ovarian cancer risks—including epidemiologist Dr. Michele Cote (October 22, 2026 Memorandum Opinion and Order, Doc. 2079) and four additional experts (November 12, 2026 Memorandum Opinion and Order, Doc. 2092)—while excluding two others.

  • Upcoming Pretrial Deadlines: Case-specific expert discovery in the bellwether pool closes on December 21, 2026, followed by a January 11, 2027 deadline for summary judgment and case-specific Rule 702 motions.

Key Litigation Milestones and Timeline

  • October 2022 – Epidemiological Study Published: A landmark National Institutes of Health (NIH) Sister Study analysis published in the Journal of the National Cancer Institute found that women who frequently used chemical hair straightening products (more than four times in the prior 12 months) were more than twice as likely to develop uterine cancer compared to non-users.

  • February 2023 – MDL Consolidation: On February 7, 2023, the JPML granted plaintiffs’ motion to centralize federal hair relaxer lawsuits in the Northern District of Illinois under MDL No. 3060.

  • March 2023 – MDL Leadership Appointed: On March 3, 2023, Judge Rowland appointed Plaintiffs’ Co-Lead Counsel, Liaison Counsel, the Plaintiffs’ Executive Committee (PEC), and the Plaintiffs’ Steering Committee (PSC) to coordinate consolidated discovery and pretrial proceedings.

  • January 2026 – Court Holds Science Day: On January 8, 2026, Judge Rowland presided over a non-adversarial Science Day where plaintiffs’ and defendants’ experts presented scientific and medical background on endocrine-disrupting chemicals, scalp absorption, and hormone-sensitive cancers.

  • Spring–Summer 2026 – Bellwether Discovery and State-Court Disputes: General causation expert discovery closed in March 2026, followed by Daubert briefing in April and May. Meanwhile, parallel state dockets saw active discovery battles, including L’Oréal USA’s June 2026 appeal in the Philadelphia County Court of Common Pleas challenging orders compelling depositions of senior company executives alongside federal MDL discovery.

  • October–November 2026 – Daubert Rulings and Cook County Settlements: Judge Rowland issued general causation expert orders on October 22 and November 12, 2026, while the first state-court trial in Cook County resolved via confidential settlements on November 16, 2026.

Products, Defendants, and Core Allegations

The litigation names major cosmetics manufacturers and parent companies, including L’Oréal USA, SoftSheen-Carson, Revlon, Strength of Nature, and Namaste Laboratories. Products frequently identified in short-form complaints and litigation filings include:

  • Dark & Lovely

  • Just for Me

  • Optimum

  • Motions

  • Olive Oil Girls

  • Soft & Beautiful

  • ORS Olive Oil

Plaintiffs assert claims for negligence, strict liability design defect, failure to warn, and breach of warranty, alleging that manufacturers marketed chemical straighteners for long-term, repeated use starting in adolescence without disclosing potential carcinogenic or endocrine-disrupting risks.

MDL No. 3060 Plaintiffs’ Leadership Structure

In March 2023, Judge Rowland appointed the following leadership team to oversee the federal proceedings (with subsequent periodic updates as litigation has progressed):

  • Plaintiffs’ Co-Lead Counsel: Benjamin L. Crump (Ben Crump Law Firm), Fidelma Fitzpatrick (Motley Rice LLC), Michael A. London (Douglas & London, P.C.), and Diandra “Fu” Debrosse Zimmermann (DiCello Levitt LLC)

  • Plaintiffs’ Liaison Counsel: Edward A. Wallace (Wallace Miller)

  • Plaintiffs’ Executive Committee (PEC): Brian Barr (Levin Papantonio Rafferty), Tim Becker (Johnson Becker), Jayne Conroy Simmons (Hanly Conroy), Kelly M. Dermody (Lieff Cabraser Heimann & Bernstein), Jennifer Hoekstra (Aylstock, Witkin, Kreis & Overholtz, PLLC), LaRuby May (May Jung), Rene F. Rocha (Morgan & Morgan), Larry Taylor (The Cochran Firm), and Navan Ward (Beasley Allen)

  • Plaintiffs’ Steering Committee (PSC): Anne Andrews (Andrews & Thornton), Greg Cade (Environmental Law Group), Thomas P. Cartmell (Wagstaff & Cartmell LLP), Andrew Childers (Childers, Schleuter & Smith), Erin Copeland (Fibich Leebron Copeland Briggs), Maria Fleming (Napoli Shkolnik), Lee Floyd (Breit Biniazan), Kendra Y. Goldhirsch (Chaffin Luhana LLP), Kristine Kraft (Schlichter Bogard & Denton), Buffy Martines (Laminack, Pirtle & Martines), Melanie Muhlstock (Parker Waichman), David A. Neiman (Romanucci & Blandin, LLC), Michelle Parfitt (Ashcraft & Gerel, LLP), Syreeta Poindexter (Babin Law), EricaRae Garcia (Weitz & Luxenberg), Steve Rotman (Hausfeld), Richard W. Schulte (Wright & Schulte LLC), Ashlie Case Sletvold (Peiffer Wolf Carr Kane Conway & Wise, LLP), Chris Stewart (Stewart Miller Simmons), Aimee Wagstaff (Wagstaff Law Firm), and Mikal Watts (Watts Guerra)

Operational Readiness: What This Phase Means for Law Firms

With more than 12,700 active federal claims, state-court proceedings advancing in Illinois, Pennsylvania, and Georgia, and the first federal bellwether trial set for September 2027, law firms face increasing pressure to verify and organize their claimant inventories. Many hair relaxer claims span decades of product usage, making historical product identification, usage frequency, and oncology record verification critical to surviving dispositive motions and future settlement audits.

As your firm prepares its docket for upcoming milestones, leadership should evaluate whether your operational infrastructure can answer five core questions:

  1. Data Completeness: Are claimant intake fields standardized and free of duplicate filings across co-counsel and internal databases?

  2. Product Identification: Are brand names, application frequencies, and approximate dates of exposure clearly documented?

  3. Medical Verification: Are pathology, oncology, and surgical records retrieved and tied directly to qualifying uterine, endometrial, or ovarian cancer diagnoses?

  4. Deficiency Management: Are incomplete Plaintiff Fact Sheets (PFS) and missing medical authorizations tracked with clear escalation workflows?

  5. Portfolio Valuation: Can your team segment inventory strength across injury types, exposure durations, and evidentiary tiers?

Implementing standardized mass tort case management workflows alongside mass tort litigation analytics services and mass tort claim auditing services enables firms to resolve documentation gaps early and scale docket operations without expanding fixed overhead.

Strengthen Your Hair Relaxer Case Operations With Verus

Verus provides comprehensive litigation support and mass tort settlement administration services to help law firms manage complex, high-volume dockets from intake through resolution. Whether your team needs support organizing claimant data, retrieving medical records, auditing fact sheets, or preparing inventories for settlement valuation, Verus delivers scalable infrastructure built for complex litigation.

Contact Verus to discuss how we can support your law firm.

Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute legal advice. Readers should consult with qualified legal counsel for advice tailored to their specific circumstances.

You might also like
Share This